Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
The Lancet. Infectious Diseases|September 13, 2025
Rifasutenizol-based triple therapy versus bismuth plus clarithromycin-based triple therapy for first-line treatment of Helicobacter pylori infection in China (EVEREST-HP): a phase 3, multicentre, randomised, triple-dummy, double-blind, controlled, non-inferiority trialZhiqiang Song, Liya Zhou, Weihong Wang, et al.
Helicobacter|July 11, 2022
Low compliance to post-screening recommendations in a family-based Helicobacter pylori screening and treatment program: A prospective cohort studyQingzhou Kong, Yueyue Li, Ruili Li, et al.
Chinese Medical Journal|April 30, 2025
The interval of rescue treatment does not affect the efficacy and safety of Helicobacter pylori eradication: A prospective multicenter observational studyMinjuan Lin, Junnan Hu, Jing Liu, et al.
Helicobacter|October 2, 2019
Management of Helicobacter pylori infection by clinicians: A nationwide survey in a developing countryConghua Song, Chuan Xie, Yin Zhu, et al.
Emerging Microbes & Infections|March 13, 2020
Long-term follow-up of <i>Helicobacter pylori</i> reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational studyYong Xie, Conghua Song, Hong Cheng, et al.
Eclinicalmedicine|September 16, 2024
Efficacy of a real-time intelligent quality-control system for the detection of early upper gastrointestinal neoplasms: a multicentre, single-blinded, randomised controlled trialRuchen Zhou, Jing Liu, Chenchen Zhang, et al.
Nature Communications|August 22, 2023
Bile acid-dependent transcription factors and chromatin accessibility determine regional heterogeneity of intestinal antimicrobial peptidesYue Wang, Yanbo Yu, Lixiang Li, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 9, 2024
Sensing of Liver-Derived Nicotinamide by Intestinal Group 2 Innate Lymphoid Cells Links Liver Cirrhosis and Ulcerative Colitis SusceptibilityJing Shen, Zhen Li, Xiaoyu Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 9, 2026
De Novo Multi-Mechanism Antimicrobial Peptide Design via Multimodal Deep LearningXiaojuan Li, Haifan Gong, Yue Wang, et al.
Cell Metabolism|July 6, 2024
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab responseMengqi Zheng, Yunjiao Zhai, Yanbo Yu, et al.
Pageof 11